Medicare Administrative Contractors and Unified Program Integrity Contractors (UPICs) auditing telehealth prescribing claims routinely go past the billing modifier and straight to the encounter note. The question is not whether the code was correct. It is whether the record proves the visit happened the way the claim says it did: by real-time audio and video, with the patient the practitioner claims to have examined, and with a prescription that follows from an identifiable clinical encounter. A prescribing record that fails that test can produce a recoupment demand, a DEA inquiry, or both, even when the underlying clinical judgment was sound.
What Counts as a Documented Telehealth Visit
CMS's Medicare Telemedicine Health Care Provider Fact Sheet separates a telehealth visit, which requires real-time interactive audio and video technology, from a virtual check-in or an e-visit, which does not. Auditors first check which category the note describes and whether that description matches the code billed. A note that says only telehealth visit without stating that the interaction was synchronous and audio-video, or a note that reads as copied from an earlier visit, counts as a documentation gap regardless of whether the underlying care was appropriate.
Proving the Visit Was Synchronous
Auditors expect the record to show, written at the time of the visit rather than reconstructed later, the platform used, the start and stop times or total time when the code is time-based, and the location of both the patient and the prescriber during the encounter. Location matters twice over: it drives the place-of-service code, and for a controlled substance prescription it determines whether the prescriber holds a license to treat a patient physically present in that state. A record built after the fact, once an audit letter arrives, is among the most commonly cited weaknesses in telehealth prescribing reviews.
A telehealth prescribing note that cannot show, on its face, that the visit was synchronous and that the patient's identity was verified leaves an auditor no way to separate a legitimate encounter from the pattern the HHS Office of Inspector General has flagged as telehealth fraud.
Identity Verification and the Findings Auditors Cite
The HHS Office of Inspector General's telehealth fraud guidance describes schemes built around a prescriber with no meaningful interaction with the beneficiary before signing an order, a hallmark OIG treats as fraud even when a call nominally took place. Auditors reviewing established practices look for the same gap on a smaller scale: no record of how identity was confirmed, no documentation tying a prescription to a dated encounter, or same-day visit volume inconsistent with the time available. The DEA's January 2025 proposed rule on Special Registrations for Telemedicine, still not finalized, would require practitioners to verify identity with a government-issued photo ID and retain the date, time, and address of every encounter for two years. The proposal has not taken effect, but it describes the same standard federal audit teams already apply informally when a chart contains no record of how identity was established.
Current Prescribing Flexibility Does Not Excuse Documentation Gaps
The temporary DEA and HHS extension of pandemic-era telemedicine flexibilities, now running through December 31, 2026, permits many practitioners to prescribe controlled substances without the in-person evaluation the Ryan Haight Act otherwise requires. That extension covers only the in-person exam requirement. The obligation to document the encounter itself, including prescription drug monitoring program checks and the clinical basis for the prescription, remains in force regardless of the extension. A prescriber who treats the flexibility as a reason to under-document the visit is building the exact record a UPIC audit is designed to find.
Why Early Legal Counsel Is Critical
It is critical that telehealth providers promptly retain experienced healthcare defense counsel upon receiving a telehealth prescribing audit notice, a UPIC records request, or any other government inquiry into prescribing documentation. Early legal intervention can protect the provider's rights, ensure that responses to identity-verification and encounter-documentation requests are accurate and complete, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with auditors or investigators on the provider's behalf. Delaying legal representation can significantly affect the outcome of a telehealth prescribing audit and expose the provider to unnecessary recoupment or referral risk.
How Health Law Alliance Can Help
Health Law Alliance defends telehealth providers, physicians, and pharmacies through UPIC and Medicare Administrative Contractor audits of telehealth prescribing records, from the initial documentation request through appeal of any recoupment or DEA referral. We review encounter notes for synchronous-visit proof, identity-verification documentation, and prescription drug monitoring program compliance before providers respond, and we represent providers in administrative appeals and related DEA and OIG inquiries. If your practice has received a telehealth prescribing audit notice or a UPIC records request, contact us for a free, confidential consultation.
